Logo-npj

Original

1. Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
Maha A. Behairy ORCID, Osama Mahmoud, Ayman Rabie Ibrahim* ORCID, Aber H. Baki ORCID
J Nephropharmacol. 2022;11(1): e5. doi: 10.34172/npj.2022.05
Scopus ID: 85119590692    
Article
PDF
XML
Cited By:
0
0

Original

2. A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
Saeed Mardani* ORCID, Faranak Sadat Filsouf ORCID
J Nephropharmacol. 2022;11(1): e12. doi: 10.34172/npj.2022.12
Scopus ID: 85119625471    
Article
PDF
XML
Cited By:
0
0